Taxanes are the most active drugs in the treatment of metastatic breast and ovarian cancer. Weekly therapy with paclitaxel produces notable activity, with remarkably low toxicity.
Henning Kühnle, MD
Advertisement
Articles by Henning Kühnle, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Which Novel Drug Classes Hold Promise in Multiple Myeloma Therapy?
2
Atirmociclib/Fulvestrant Improves PFS in HR+/HER2– Breast Cancer
3
From Blunt Instruments to Molecular Precision: 40 Years of Oncology Evolution
4
FDA Approves Companion Diagnostic for Niraparib in Advanced Ovarian Cancer
5